1-20 of 13,717 results for subject:Diseases
Librarians' tools
- Search time
- 0.344 seconds
- Solr query time
- 0.021 seconds
- Search query
- subject:Diseases
- We searched for
- subject_t:Diseases OR subject_t:Epidemics OR subject_t:"Health conditions" OR subject_t:Illnesses OR subject_t:"Medical conditions" OR subject_t:"Medical disorders" OR subject_t:Pandemics OR subject_t:Syndromes OR subject_ses:90934
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential implications for its policies of the "Improving affordable access to essential medicines, diagnostics and health technologies for children and adolescents living with noncommunicable diseases (NCDs)" proposal submitted to the World...
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential implications for its policies of the "Improving affordable access to essential medicines, diagnostics and health technologies for children and adolescents living with noncommunicable diseases (NCDs)" proposal submitted to the World...
The National Health Service provides care free at the point of delivery, therefore children and adolescents living with noncommunicable diseases in the United Kingdom have free access to essential medicines, diagnostics, and health technologies.
To ask His Majesty's Government whether they are satisfied that the NHS Dorset Integrated Care Board is following national guidelines in prescribing T3 to patients who do not respond to Levothyroxine monotherapy.
To ask His Majesty's Government whether they are satisfied that the NHS Dorset Integrated Care Board is following national guidelines in prescribing T3 to patients who do not respond to Levothyroxine monotherapy.
The NHS Dorset Integrated Care Board (ICB) recognises the importance of ensuring that local prescribing policies and formulary guidance are consistent with relevant national guidance, including NHS England's advice for prescribers for liothyronine, also known as T3, from August 2023, and the National Institute for Health and Care Excellence’s guideline Thyroid disease: assessment and management, reference code NG145. NHS England's guidance recognises that while levothyroxine remains the standard treatment for hypothyroidism, a small proportion of patients who continue to experience symptoms despite adequate levothyroxine treatment may be considered for liothyronine following specialist assessment by a National Health Service consultant endocrinologist.
The ICB has previously acknowledged the need for local formulary wording to be clear and aligned with NHS England guidance and has undertaken review work to ensure that local guidance appropriately reflects the role of specialist assessment, individualised clinical decision-making, and shared care arrangements where clinically appropriate.
NHS Dorset continues to review prescribing arrangements to ensure they are informed by specialist endocrinology advice and seek to support safe, evidence-based, and patient-centred care. Prescribing decisions for individual patients are made by appropriately qualified clinicians based on clinical need, specialist advice, patient preference, and the available evidence. NHS Dorset supports clinicians in exercising professional judgement.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of (a) making it easier for people with degenerative diseases to obtain NHS Continuing Healthcare (CHC) funding and (b) removing the requirement for people with degenerative diseases to be assessed...
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of (a) making it easier for people with degenerative diseases to obtain NHS Continuing Healthcare (CHC) funding and (b) removing the requirement for people with degenerative diseases to be assessed...
The Department works with partners, including NHS England, external organisations and people with lived experience, to seek feedback on NHS Continuing Healthcare policy and implementation. This includes seeking feedback on how people with degenerative diseases can access NHS Continuing Healthcare funding as quickly as possible where they are assessed as eligible.
The Department has published national guidance which states that when undertaking a full Standard NHS Continuing Healthcare assessment, the multidisciplinary team should ideally include someone with specialist knowledge of the individual’s condition. The guidance also sets out that individuals with a rapidly deteriorating condition, who may be entering a terminal phase, may be eligible for Fast Track Continuing Healthcare. NHS England has also commissioned an Information and Advice Service for NHS Continuing Healthcare which provides independent, free advice for individuals and families navigating the process.
The NHS Continuing Healthcare assessment process is required to determine whether an individual’s needs mean they are eligible for NHS Continuing Healthcare. Where eligible, the integrated care board is responsible for commissioning a package which meets all the individual’s assessed health and associated care and support needs.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to mitigate the impacts of extreme hot weather for older adults and people with underlying medical conditions.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to mitigate the impacts of extreme hot weather for older adults and people with underlying medical conditions.
I refer the Hon Member to the report published by the UK Health Security Agency on excess deaths linked to the heatwaves in May and June, available at the link below, and to the accompanying response from my Rt Hon. Friend, the Secretary of State for Health and Social Care:
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the potential impact of Tropical Race 4 on the level of Cavendish Bananas imported in the next 12 months.
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the potential impact of Tropical Race 4 on the level of Cavendish Bananas imported in the next 12 months.
Defra cannot comment on the volume of trade and availability on the market. The Department can confirm there will be no phytosanitary impacts on imports of bananas into the UK during the next 12 months because of Fusarium oxysporum f. sp. cubense Tropical Race 4 (TR4).
To ask His Majesty's Government whether they are satisfied that the NHS Dorset integrated care board is following national guidelines in prescribing T3 to patients who do not respond to Levothyroxine mono-therapy.
To ask His Majesty's Government whether they are satisfied that the NHS Dorset integrated care board is following national guidelines in prescribing T3 to patients who do not respond to Levothyroxine mono-therapy.
Motion to consider. Agreed to on question.
Motion to consider. Agreed to on question.
Antifungal resistance happens when fungal infections stop responding to antifungal medicines.
Antifungal resistance happens when fungal infections stop responding to antifungal medicines.
I. The UK Government Resilience Action Plan: 2026. Implementation report. 22p. II. The National Risk Register and supporting guidance. 25p. III. National Risk Register 2026. 223p. IV. Letter dated 14/07/2026 from Darren Jones MP to the Deposited Papers Clerk regarding the two documents for deposit in the House libraries. 1p.
I. The UK Government Resilience Action Plan: 2026. Implementation report. 22p. II. The National Risk Register and supporting guidance. 25p. III. National Risk Register 2026. 223p. IV. Letter dated 14/07/2026 from Darren Jones MP to the Deposited Papers Clerk regarding the two documents for deposit in the House libraries. 1p.
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) are health conditions that affect some children following an infection.
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) are health conditions that affect some children following an infection.
I. Deaths registered summary statistics, England and Wales: 2025. (13 tables). II. Letter dated 08/06/2026 from Satvir Kaur MP to the Deposited Papers Clerk regarding the Office of National Statistics' Annual Abstract of Deaths, for deposit in the House Libraries. 1p.
I. Deaths registered summary statistics, England and Wales: 2025. (13 tables). II. Letter dated 08/06/2026 from Satvir Kaur MP to the Deposited Papers Clerk regarding the Office of National Statistics' Annual Abstract of Deaths, for deposit in the House Libraries. 1p.
To ask His Majesty's Government which notifiable diseases have been confirmed in (1) pheasants, and (2) red-legged partridges, in the last five years; and whether there is evidence of transmission to wild birds for any of these diseases.
To ask His Majesty's Government which notifiable diseases have been confirmed in (1) pheasants, and (2) red-legged partridges, in the last five years; and whether there is evidence of transmission to wild birds for any of these diseases.
In the last five years there have confirmed cases of both low pathogenic avian influenza (LPAI) and highly pathogenic avian influenza (HPAI) on premises containing pheasants. Some premises confirmed with HPAI and LPAI have also had red-legged partridges. There have also been findings in both species in found dead wild birds tested as part of wild bird surveillance.
Epidemiological investigations at infected premises did not find any evidence to support likely transmission from farmed gamebirds to wild birds on these premises.
Compare local data for health conditions including diabetes, asthma, depression and high blood pressure.
Compare local data for health conditions including diabetes, asthma, depression and high blood pressure.
Find out about who is eligible for infected blood compensation, how the scheme processes claims for compensation and support for claimants.
Find out about who is eligible for infected blood compensation, how the scheme processes claims for compensation and support for claimants.
To ask the Secretary of State for Health and Social Care, what consideration his Department has given to the integration of recommendations from the Getting It Right First Time programme for gastroenterology into the national quality strategy.
To ask the Secretary of State for Health and Social Care, what consideration his Department has given to the integration of recommendations from the Getting It Right First Time programme for gastroenterology into the national quality strategy.
We recognise the value of clinically‑led improvement programmes such as Getting It Right First Time (GIRFT) in identifying and addressing unwarranted variation in care, including in gastroenterology. Rather than being incorporated into the National Quality Strategy, which will set out overarching principles and priorities for improving quality, GIRFT recommendations are developed through detailed clinical engagement, analysis of national data, and close working with professional bodies, providers, and systems. Specialty‑specific recommendations from programmes such as GIRFT are used to inform delivery at national, regional, and local levels, rather than being incorporated as prescriptive elements of the strategy itself.
To ask His Majesty's Government what steps they are taking to secure supplies of medicines, medical devices and medical consumables in the case of war or pandemic; and whether those steps include building and maintaining strategic reserves of those supplies.
To ask His Majesty's Government what steps they are taking to secure supplies of medicines, medical devices and medical consumables in the case of war or pandemic; and whether those steps include building and maintaining strategic reserves of those supplies.
It has not proved possible to respond to this question in the time available before Prorogation. Ministers will correspond directly with the Member.
To ask the Secretary of State for Business and Trade, whether the Parental Leave and Pay review is considering the ability for individuals with severe illness, such as cancer, to postpone maternity leave.
To ask the Secretary of State for Business and Trade, whether the Parental Leave and Pay review is considering the ability for individuals with severe illness, such as cancer, to postpone maternity leave.
A cancer diagnosis is distressing at any stage of life, and especially for mothers on maternity leave, at a time that should be focused on recovery, bonding and family life.
The Department of Health and Social Care’s National Cancer Plan sets out how people with cancer, including pregnant and postnatal women, are supported before, during and after treatment, including supporting mothers to stay in work.
Alongside this, the Parental Leave and Pay Review is examining how maternity leave and the wider parental leave and pay system can better support working families. The Review will report in early 2027.
To ask His Majesty's Government what steps they take when funding medical research to ensure that diseases common to males and females are studied on a separate gender basis rather than a male-only basis.
To ask His Majesty's Government what steps they take when funding medical research to ensure that diseases common to males and females are studied on a separate gender basis rather than a male-only basis.
Through our National Institute for Health and Care Research (NIHR), we are actively committed to ensuring there is more research into women’s health, and that women’s voices and priorities are placed at the heart of this research.
We know that women have been under-represented in some research areas, particularly women in ethnic minority groups, older women, women of reproductive age, disabled women and LGBT+ women. This has implications for the health and care they receive, their options and awareness of treatments, the support they can access afterwards, and their health outcomes. To address this gap, applicants are now required to build inclusion into their research design as a condition of NIHR funding.
As highlighted in the newly published Renewed Women’s Health Strategy for England, the Department has strengthened NIHR conditions of funding by making it mandatory for researchers to account for sex and gender in their research applications. This move aims to tackle significant and persistent gaps in health and care research.
Alongside this, the NIHR’s Research Inclusion Strategy 2022-2027 sets out how NIHR will become a more inclusive funder of research and widen access to participation in clinical trials. The strategy has been designed to address inequalities associated with the protected characteristics of the Equality Act 2010.
Through the ongoing systematic collection of data on sex, ethnicity and age of participants taking part in NIHR research, we can monitor progress and continue to champion the inclusion of under-represented groups.
To ask the Secretary of State for Health and Social Care, what proportion of the new anti-stigma programmes commissioned across trusts will be delivered in partnership with voluntary and community sector organisations with lived experience expertise, and how this will be monitored.
To ask the Secretary of State for Health and Social Care, what proportion of the new anti-stigma programmes commissioned across trusts will be delivered in partnership with voluntary and community sector organisations with lived experience expertise, and how this will be monitored.
As part of the blood borne virus (BBV) emergency department opt-out testing programme, NHS England currently promotes and funds HIV peer support services in partnership with voluntary and community sector organisations, recognising the role of lived-experience facilitators in reducing isolation and stigma.
NHS England is in the process of commissioning new HIV anti‑stigma training as part of delivery of the HIV Action Plan, for trusts participating in the BBV emergency department opt‑out testing programme. NHS England strongly expects a voluntary and community sector partner with lived experience expertise to lead this work, recognising the critical role such organisations play in tackling stigma and discrimination effectively. Delivery of the programme will be overseen by the national BBV emergency department opt‑out team. Progress will be monitored through quarterly meetings and update reports, aligned to the agreed deliverables, including trust engagement and risk management.